Stay updated on Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial page.

Latest updates to the Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding-lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding status and the NIH Clinical Center operations, and updated the page version to v3.4.1. The previous version note v3.4.0 was removed.SummaryDifference0.4%

- Check28 days agoChange DetectedShow glossary toggle is now displayed, and meta-text was updated to 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing v3.3.3, with no changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a global Locations section with state-specific subsections (New South Wales, Queensland, Tasmania, Victoria, Western Australia) and a revision note (v3.3.3); removed the HHS Vulnerability Disclosure link and the prior region-specific location subsections (v3.3.2).SummaryDifference0.6%

- Check92 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed; this is a minor metadata update with no impact on study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial page.